Skip to main content
. 2022 Nov 28;13(4):100668. doi: 10.1016/j.jaim.2022.100668

Table 2.

Changes in objective assessment criteria.

S.No. Symptoms Before After
1 Itching Severe Mild/No
2 Macular Nodules Severe Mild/No
3 Oozing Mild No
4 Bleeding Mild No